Current roles
Ken James is the Head of R&D. He oversees the development, regulatory, quality and manufacturing strategies for the Group’s existing pipeline and the evaluation of early stage pipeline opportunities. He is also an Executive Director.
Past roles
Senior Vice President of Research and Development for GlaxoSmithKline Worldwide Consumer Healthcare, having worked in the UK and the United States.
Brings to the Board
Over 40 years’ experience in the research, development and commercialisation of consumer healthcare products.